HTLV-I/II and blood donors: Determinants associated with seropositivity in a low risk population

27Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Objective. Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was performed to estimate the prevalence of HTLV-I/II infection in a low risk population and to better understand determinants associated with seropositivity. Methods. HTLV-I/II seropositive (n=135), indeterminate (n=167) and seronegative blood donors (n=116) were enrolled in an open prevalence prospective cohort study. A cross-sectional epidemiological study of positive, indeterminate and seronegative HTLV-I/II subjects was conducted to assess behavioral and environmental risk factors for seropositivity. HTLV-I/II serological status was confirmed using enzyme-linked immunosorbent assay (EIA) and Western blot (WB). Results. The three groups were not homogeneous. HTLV-I/II seropositivity was associated to past blood transfusion and years of schooling, a marker of socioeconomic status, and use of non-intravenous illegal drugs. Conclusions. The study results reinforce the importance of continuous monitoring and improvement of blood donor selection process.

Cite

CITATION STYLE

APA

Catalan Soares, B., de F Carneiro Proietti, A. B., & Proietti, F. A. (2003). HTLV-I/II and blood donors: Determinants associated with seropositivity in a low risk population. Revista de Saude Publica, 37(4), 470–476. https://doi.org/10.1590/s0034-89102003000400012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free